Patient Engagement Suite

  1. Beyond The Pandemic: Why eCOAs Are Here To Stay 4/29/2022

    The permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.

  2. Reducing Risks And Accelerating Study Startup Through An eCOA Library 4/28/2022

    Find out how the shift towards a more patient-centric drug development landscape has made Clinical Outcome Assessments (COAs) an increasingly necessary and often required tool to gather patient experience data in most trials today.

  3. Fighting COVID-19 Like A Pro 4/28/2022

    Explore how the use of electronic Clinical Outcomes Assessments (eCOAs) can be rapidly implemented to capture patient reported outcomes (PROs).

  4. Going Global With eConsent 4/20/2022

    Scott Askin paints the picture of why Novartis, determined to improve the patient experience, has begun to deploy eConsent, and what they’ve learned along the way.

  5. Protocol Amendments And Electronic Consent: Overcoming The Challenges To Reap The Benefits 3/29/2022

    Learn about some insights that have been gleaned from experience deploying eConsent on diverse trial types around the world.

  6. IRT And Direct-To-Patient Trials 1/12/2022

    Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.

  7. Harness The Power Of eCOA In Your Next Trial

    In this webinar, explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them.

  8. Patient Data: The Backbone Of Your Clinical Trial

    In clinical trials, data capture is typically centered around patients’ experiences with a drug. See why electronic clinical outcome assessments (eCOAs) are essential to patient data capture.

  9. Improving Supply Chain: Accountability, Sustainability, Optimization

    Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.